Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Hopkinson Craig C.
EVP R&D, Chief Medical Officer at Alkermes. Filing since 15 Apr 2021.
CIK 0001730048
Company
Date
Role
Action
Shares
Amount
Of holding
ALKS
Alkermes plc.
1 Sep 2026
EVP R&D, Chief Medical Officer
Sold on a plan
9,000
$422.87K
12.1%
ALKS
Alkermes plc.
3 Aug 2026
EVP R&D, Chief Medical Officer
Sold on a plan
9,000
$437.22K
11.5%
ALKS
Alkermes plc.
1 Jul 2026
EVP R&D, Chief Medical Officer
Sold on a plan
9,000
$463.62K
10.9%
ALKS
Alkermes plc.
1 Jun 2026
EVP R&D, Chief Medical Officer
Sold on a plan
9,000
$375.04K
10.4%
ALKS
Alkermes plc.
1 May 2026
EVP R&D, Chief Medical Officer
Sold on a plan
9,000
$300.56K
10.0%
ALKS
Alkermes plc.
1 Apr 2026
EVP R&D, Chief Medical Officer
Sold on a plan
9,000
$319.60K
9.5%
ALKS
Alkermes plc.
2 Mar 2026
EVP R&D, Chief Medical Officer
Sold on a plan
9,000
$267.49K
9.1%
ALKS
Alkermes plc.
2 Feb 2026
EVP R&D, Chief Medical Officer
Sold on a plan
9,000
$305.38K
13.5%
ALKS
Alkermes plc.
8 Jan 2026
EVP R&D, Chief Medical Officer
Sold on a plan
5,000
$150.01K
7.5%
ALKS
Alkermes plc.
2 Jan 2026
EVP R&D, Chief Medical Officer
Sold on a plan
4,000
$112.00K
6.1%
ALKS
Alkermes plc.
3 Dec 2025
EVP R&D, Chief Medical Officer
Sold on a plan
3,748
$112.45K
5.4%
ALKS
Alkermes plc.
1 Dec 2025
EVP R&D, Chief Medical Officer
Sold on a plan
4,000
$117.20K
5.7%
ALKS
Alkermes plc.
3 Nov 2025
EVP R&D, Chief Medical Officer
Sold on a plan
9,000
$273.44K
11.4%
ALKS
Alkermes plc.
15 Oct 2025
EVP R&D, Chief Medical Officer
Sold on a plan
9,000
$283.78K
10.9%
ALKS
Alkermes plc.
13 Feb 2025
EVP R&D, Chief Medical Officer
Sold on a plan
144,419
$5.13M
71.4%
ALKS
Alkermes plc.
12 Feb 2025
EVP R&D, Chief Medical Officer
Sold on a plan
204,921
$6.72M
78.0%
ALKS
Alkermes plc.
30 Jan 2025
EVP R&D, Chief Medical Officer
Sold on a plan
100,918
$3.23M
69.5%
ALKS
Alkermes plc.
9 Dec 2024
EVP R&D, Chief Medical Officer
Sold on a plan
61,151
$1.96M
56.2%
ALKS
Alkermes plc.
5 Dec 2024
EVP R&D, Chief Medical Officer
Sold on a plan
9,221
$290.46K
13.4%
ALKS
Alkermes plc.
4 Dec 2024
EVP R&D, Chief Medical Officer
Sold on a plan
14,349
$441.55K
17.2%
ALKS
Alkermes plc.
11 Nov 2024
EVP R&D, Chief Medical Officer
Sold on a plan
58,996
$1.77M
41.5%
ALKS
Alkermes plc.
6 Nov 2024
EVP R&D, Chief Medical Officer
Sold on a plan
10,471
$309.17K
9.5%
ALKS
Alkermes plc.
23 Feb 2022
EVP R&D, Chief Medical Officer
Sold, plan not stated
11,983
$296.65K
40.0%
ALKS
Alkermes plc.
18 Feb 2022
EVP R&D, Chief Medical Officer
Sold, plan not stated
2,306
$58.04K
19.5%
ALKS
Alkermes plc.
9 Jun 2021
EVP R&D, Chief Medical Officer
Sold, plan not stated
882
$21.70K
100%
ALKS
Alkermes plc.
15 Apr 2021
EVP R&D, Chief Medical Officer
Sold, plan not stated
28,920
$570.29K
100%
26 decisions on file.
